Related Experiment Video
Updated: Mar 29, 2026

Seven Steps to Stellate Cells
Published on: May 10, 2011
Cytoglobin in Hepatic Stellate Cells Plays Anti-Fibrotic Role in Chronic Liver Injury
1Departments of Homeostatic Regulation and Liver Cancer Treatment, Graduate School of Medicine, Osaka Metropolitan University, Osaka 545-8585, Japan.
Insights
Cytoglobin (Cygb) protects the liver from fibrosis and inflammation by regulating hepatic stellate cell activation. This antioxidant protein shows promise for treating liver cirrhosis and cancer.
Area of Science:
- Hepatology
- Molecular Biology
- Cell Biology
Background:
- Cytoglobin (Cygb) is a cytoplasmic globin primarily found in hepatic stellate cells (HSCs).
- Its role in liver physiology was initially unclear but is now recognized as protective.
- Emerging evidence highlights Cygb's involvement in liver disease pathogenesis, including fibrosis and cancer.
Purpose of the Study:
- To elucidate the protective mechanisms of Cytoglobin (Cygb) in liver injury.
- To investigate the role of Cygb in liver fibrosis, inflammation, and hepatocarcinogenesis.
- To explore the therapeutic potential of Cygb in liver diseases.
Main Methods:
- Utilized Cygb-deficient mouse models to study liver injury.
- Analyzed human liver tissues and cell-based models.
- Investigated Cygb's function as an antioxidant and its effect on signaling pathways.
Main Results:
- Cygb deficiency exacerbates liver injury, fibrosis, and inflammation.
- Cygb regulates HSC activation, maintaining hepatic homeostasis.
- Cygb mitigates oxidative stress, impacting TGF-β signaling and fibrogenic responses.
- CYGB is implicated in human liver pathology and hepatocarcinogenesis.
Conclusions:
- Cytoglobin (Cygb) plays a crucial protective role in the liver against injury and disease.
- Cygb's antioxidant properties are key to its protective effects.
- Therapeutic strategies using recombinant CYGB are being developed for liver cirrhosis treatment.
Abstract:
Cytoglobin (Cygb) was discovered in 2001 as a cytoplasmic globin predominantly expressed in hepatic stellate cells (HSCs). While its initial physiological role remained elusive, subsequent studies using Cygb-deficient mouse models of liver injury have demonstrated that Cygb exerts protective effects against liver fibrosis and inflammation. It achieves this by regulating HSC activation, thereby preserving hepatic homeostasis. Furthermore, accumulating evidence suggests a significant role for Cygb in hepatocarcinogenesis. Analysis of human liver tissues and cell-based models has further confirmed the critical involvement of CYGB in liver pathology. Functionally, Cygb acts as an antioxidant protein that mitigates oxidative stress, a property that appears to modulate transforming growth factor-beta signaling and downstream fibrogenic responses. Based on these findings, therapeutic strategies employing recombinant CYGB for the treatment of human liver cirrhosis are currently being explored, and their potential clinical applications are eagerly anticipated.
Related Concept Videos
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Introduction to Fibroblasts
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Hepatitis

